Advertisement
In U.S. veterans aged 75 years and older

Statin Use May Cut All-Cause, CVD Mortality in Those 75 and Older

0
Reductions in risk seen for all-cause, CV mortality and composite of atherosclerotic CV events
From February to March 2020

February to March 2020 Saw Surge in Hydroxychloroquine Rx

0
Number of patients receiving hydroxychloroquine, chloroquine prescriptions climbed across the U.S.
The American Cancer Society has updated guidelines on human papillomavirus vaccination

American Cancer Society Updates HPV Vaccination Guidelines

0
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26
More than 70

Employers Can Refuse to Provide Birth Control Coverage: U.S Supreme Court

0
Lower courts had previously blocked changes to a requirement in the Affordable Care Act
Upadacitinib monotherapy results in improved outcomes versus methotrexate for patients with predominantly early rheumatoid arthritis

Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis

0
Significantly better clinical, radiographic, patient-reported outcomes seen with upadacitinib
Late-stage human trials to assess whether a double antibody cocktail can prevent and treat COVID-19 infection have started

COVID-19 Antibody Cocktail Begins Late-Stage Human Trials

0
Trial will assess whether it can prevent infection among uninfected people in close contact with an infected person
Efforts to reduce new HIV infections in children worldwide are faltering

Efforts to Reduce New HIV Infections in Children Faltering

0
New estimates show that 150,000 children were newly infected with HIV in 2019
For people with multiple sclerosis

Complementary, Alternative Medicine Use Increasing for MS

0
Ninefold increase observed in likelihood of patients speaking to their neurologist about CAM use
Pre/probiotic therapy may be useful for patients with depression and/or anxiety disorders

Review: Pre/Probiotics May Be Useful for Depression, Anxiety

0
All seven studies demonstrated significant improvements in one or more of the outcomes measured
Prescriptions for oral steroid bursts are associated with a 1.8- to 2.4-fold increased risk for severe adverse events within the first month after initiation of drug therapy

Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events

0
Highest rates of adverse events seen within first month after initiating short course of oral steroids